Bush vetoes stem-cell bill, disappoints advocates

Wed Jun 20, 2007 7:00pm EDT
 
[-] Text [+]

By Thomas Ferraro

WASHINGTON (Reuters) - President George W. Bush vetoed legislation on Wednesday that would expand federally funded embryonic stem cell research, triggering an uphill battle to override him in the Democratic-led U.S. Congress and likely pushing the issue onto the 2008 election agenda.

Two-thirds majority votes would be needed in the Senate and House of Representatives to overcome Bush's opposition and make the bill law. Backers admitted they were short of support. A few dozen of Bush's Republicans in Congress back the measure.

The president and other critics condemn the legislation as morally offensive because it would lead to the destruction of human embryos to derive stem cells.

"If this legislation became law, it would compel American taxpayers for the first time in our history to support the deliberate destruction of human embryos," Bush said. "I will not allow our nation to cross this moral line."

Advocates such as the nonprofit Society for Women's Health Research said Bush's decision was the unethical one, especially as the embryos that would be used are left over from fertility treatments and destined to be discarded.

"There should be no ethical debate between throwing away embryos that already exist and using them in the scientific quest for treatments and cures of fatal and life-threatening diseases," the group said in a statement.

"It is a tragedy to allow embryos to be wasted and discarded, when we could be exploring their unique potential to alleviate human suffering."

Embryonic stem cells are the source of every cell, tissue and organ in the body. Scientists study them to understand the biology not only of disease, but of life itself, and want to use them to transform medicine and find cures for such debilitating illness as Parkinson's, cancer and diabetes.

In addition to vetoing such legislation for the second time in two years, Bush issued an executive order to encourage scientists to work with the federal government to derive new methods to obtain stem cells without harming human embryos. He announced no new funding.

The Campaign for the Advancement of Medical Research, a lobby group made up of medical and advocacy groups, called the executive order a sham.

"The new approaches addressed by the order are still in the early stages of development and appear to already be eligible for National Institutes of Health funding," the group said in a statement.

WIDE BACKING

Polls show the stem-cell bill is backed by more than 60 percent of American voters.

"Once again, the president has ignored the will of the American people, of leading medical researchers, and of a bipartisan majority of the Congress," said House Speaker Nancy Pelosi, a California Democrat.

Republican Sen. George Voinovich of Ohio backed Bush, saying, "We can and must find cutting-edge techniques to cure disease and ease suffering without destroying life."  Continued...

 
Dr. Qurrath U. Ain of the Elmhurst Pediatric Emergency Center examines a patient with flu-like symptoms at Elmhurst Hospital in New York in this December 12, 2003. file photo. REUTERS/Shannon Stapleton/Files
Healthcare Reform

Reuters provides an in-depth look at the issues facing Americans as the Obama administration wrestles with healthcare policy.  Full Coverage 

Photo

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
Uninsured patient Josefa Martinez, 8, has her blood pressure measured during a health check-up at Venice Family Clinic in Venice, California, June 25, 2009.  REUTERS/Lucy Nicholson
The healthcare disconnect

A successful reform package will have to address the cost for services for private versus public providers and employ innovative technological advances, writes Darrell West, author of Digital Medicine: Health Care in the Internet Era.  Commentary | Full Coverage 

Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better